Clinical Trial Update: An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients [Phase 2]

View source ↗

Summary

A Phase 2 extension protocol investigates dose comparisons of leucine-metformin combinations in adults with type 2 diabetes mellitus; study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Leucine-Metformin combination (leucine-metformin)

Snippet

Sponsor: NuSirt Biopharma | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2017-12-18